Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients
- 1 May 1997
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 51 (5) , 1608-1612
- https://doi.org/10.1038/ki.1997.221
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Increased low density lipoprotein oxidation in stable kidney transplant recipientsKidney International, 1996
- Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin EKidney International, 1995
- Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysisKidney International, 1994
- CYCLOSPORINE INCREASES THE OXIDIZABILITY OF LOW-DENSITY LIPOPROTEINS IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1994
- Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart diseaseAtherosclerosis, 1994
- Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium.Hypertension, 1993
- Increased lipid peroxidation in cyclosporin-treated heart transplant recipientsThe American Journal of Cardiology, 1991
- Long-term complications of renal transplantationKidney International, 1990
- HYPERTENSION AFTER RENAL TRANSPLANTATIONTransplantation, 1987
- IMPAIRMENT OF THE IMMUNE RESPONSE TO INFLUENZA VACCINATION IN RENAL TRANSPLANT RECIPIENTS BY CYCLOSPORINE, BUT NOT AZATHIOPRINETransplantation, 1986